Serum Institute of India has initiated the process, according to report by news agency ANI.The COVID-19 vaccine was developed by the Jenner Institute, a part of the Nuffield Department of Medicine at the University of Oxford.
The formulation is backed by by AstraZeneca PLC, a British-Swedish pharmaceutical company. AstraZeneca joined hands with Indian vaccine maker Serum Institute of India to manufacture COVID-19 vaccine for low-and-middle income countries.Earlier this month, Drugs Controller General of India gave nod to conduct advanced trials in India. "Phase 2/3 clinical trial will be observer-blind, randomised, controlled study to determine the safety and immunogenicity of Covishield (COVID-19 vaccine) in healthy Indian adults,".